ADVANCED DEVELOPMENT, VALIDATION AND FDA CLEARANCE OF THE CELLRADX POINT OF CARE BIODOSIMETRY SYSTEM
$10,877,462
| Recipient | ASELL, LLC UEI ZC5MF9MRE3A5 |
|---|---|
| Award ID | 75A50122C00050 |
| Award amount | $10,877,462 |
| Award type | DEFINITIVE CONTRACT |
| Awarding agency | Department of Health and Human Services — Office of Assistant Secretary for Preparedness and Response |
| NAICS | 541714 — RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) |
| PSC | AN13 |
| Set-aside | Unrestricted |
| Start date | Sep 12, 2022 |
| End date | Jul 11, 2024 |
| Place of performance | OWINGS MILLS, MD |
| Record updated | Sep 12, 2022 |
View the official award record
More awards won by ASELL, LLC
DEVELOPMENT OF RADIATION/NUCLEAR MEDICAL COUNTERMEASURES (MCMS) AND BIODOSIMETRY DEVICES. 7/1/26 - 6/30/27. EO 14271: DAP-NCAP-00000073
Department of Health and Human Services · $1,492,621 · Jul 1, 2026
Our catalog shows awards with a value or ceiling of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.
Awards tell you who won. Bids tell you what's next. BidCatch scans 100+ federal, state, and local sources every night and sends the new opportunities matching your trade — before they're awarded to someone else. $0 today for 14 days (card required), then $49.99/month.
Search open bids